Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New steroidal lactones from M. crassissima disclosed by PharmaMar

Nov. 23, 2011

Bendamustine evaluated in anaplastic glioma

Nov. 23, 2011

Cabozantinib trial begins in hormone receptor-positive breast cancer

Nov. 22, 2011

Merrimack Pharmaceuticals begins enrollment in MM-121/erlotinib combination trial

Nov. 22, 2011

FDA approves Erwinaze for acute lymphoblastic leukemia

Nov. 22, 2011

Maximum tolerated dose of LDE-225 determined in patients with solid tumors

Nov. 22, 2011

FDA reaches final decision on Avastin for metastatic breast cancer

Nov. 21, 2011

Mologen's phase I/II study of cell-based renal cancer therapy meets primary endpoint

Nov. 21, 2011

AstraZeneca receives positive CHMP opinion for vandetanib

Nov. 21, 2011

NCI commences phase I trial of AZD-7451 for gliomas

Nov. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.